CVSA Covista Inc. Common Shares
حول Covista Inc. Common Shares نظرة عامة على الشركة من ويكيبيديا
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
اقرأ المزيد
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.
History
DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.
In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.
In November 2013, DeVry Inc. was renamed DeVry Education Group.
Rebranding from DeVry Education Group to Adtalem Global Education
Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.
Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."
The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.
Acquisitions and divestitures
Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.
At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.
Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.
Operations
Campuses and enrollment
Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.
Leadership
Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.
Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.
Finances
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.
Controversies
Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.
Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.
For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.
As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.
In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.
A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.
In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.
In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.
In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
CVSA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
CVSA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
| تاريخ الاستحقاق | المبلغ |
|---|---|
| 30 نوفمبر، 2016 | $0,1800 |
| 1 يونيو، 2016 | $0,1800 |
| 2 ديسمبر، 2015 | $0,1800 |
| 3 يونيو، 2015 | $0,1800 |
| 3 ديسمبر، 2014 | $0,1800 |
| 4 يونيو، 2014 | $0,1700 |
| 4 ديسمبر، 2013 | $0,1700 |
| 5 يونيو، 2013 | $0,1700 |
| 28 نوفمبر، 2012 | $0,1700 |
| 19 يونيو، 2012 | $0,1500 |
| 6 ديسمبر، 2011 | $0,1500 |
| 16 يونيو، 2011 | $0,1200 |
| 8 ديسمبر، 2010 | $0,1200 |
| 11 يونيو، 2010 | $0,1000 |
| 9 ديسمبر، 2009 | $0,1000 |
| 12 يونيو، 2009 | $0,0800 |
| 10 ديسمبر، 2008 | $0,0800 |
| 17 يونيو، 2008 | $0,0600 |
| 12 ديسمبر، 2007 | $0,0600 |
| 14 يونيو، 2007 | $0,0500 |
CVSA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 4 40,0%
- شراء 5 50,0%
- احتفاظ 1 10,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
4 محللين · 2026-08-18سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $2.09 | $1.93 | 0.16% |
| 31 مارس، 2026 | $1.98 | $1.76 | 0.22% |
| 31 ديسمبر، 2025 | $2.43 | $2.23 | 0.20% |
| 30 سبتمبر، 2025 | $1.75 | $1.61 | 0.14% |
| 30 يونيو، 2025 | $1.66 | $1.56 | 0.10% |
| 31 مارس، 2025 | $1.92 | $1.69 | 0.23% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| CVSA | $4.24B | 17.7 | 9.3% | 12.9% | 17.8% | — |
| DUOL | $8.18B | 20.5 | 38.7% | 39.9% | 35.6% | 72.2% |
| LAUR | $4.81B | 17.8 | 8.6% | 16.6% | 26.2% | — |
| GHC | — | 16.5 | 2.5% | 5.9% | 6.5% | — |
| LOPE | $4.56B | 21.6 | 7.1% | 19.5% | 28.3% | — |
| BFAM | $5.64B | 30.2 | 9.2% | 6.6% | 14.1% | 23.8% |
| LRN | $3.58B | 12.1 | 4.7% | 13.4% | 21.3% | 37.8% |
| MH | $2.62B | 72.1 | 0.07% | 1.7% | 4.6% | 80.9% |
| PRDO | $1.83B | 12.1 | 24.2% | 18.9% | 16.3% | — |
| STRA | $1.84B | 14.8 | 4.0% | 10.0% | 7.6% | — |
| UTI | $1.77B | 28.8 | 14.1% | 7.5% | 20.3% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Cost of Revenue | $834M | $771M | $699M | $648M | $660M | · | · | · | |
| SG&A Expense | $731M | $672M | $633M | $586M | $566M | · | · | · | |
| Operating Expenses | $1.57B | $1.45B | $1.37B | $1.28B | $1.31B | · | · | · | |
| Operating Income | $383M | $342M | $217M | $168M | $77M | · | · | · | |
| Interest Expense | $45M | $52M | $64M | $63M | $129M | · | · | · | |
| Interest Income | · | · | · | · | $4M | · | · | · | |
| Other Non-op | $7M | $9M | $11M | $7M | $1M | · | · | · | |
| Pretax Income | $345M | $299M | $164M | $112M | $-51M | · | · | · | |
| Income Tax | $78M | $66M | $26M | $10M | $-16M | · | · | · | |
| Net Income | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| EPS (Basic) | $7.18 | $6.39 | $3.47 | $2.08 | $6.43 | · | · | · | |
| EPS (Diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · | |
| Shares (Basic) | 35,045,000 | 37,085,000 | 39,413,000 | 44,781,000 | 48,388,000 | · | · | · | |
| Shares (Diluted) | 35,715,000 | 38,334,000 | 40,307,000 | 45,600,000 | 48,388,000 | · | · | · | |
| EBITDA | $383M | $342M | $217M | $168M | $80M | · | · | · |
الميزانية العمومية 28
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $200M | $219M | $272M | $347M | $275M | $416M | $67M | |
| Short-term Investments | · | · | · | · | · | · | · | $9M | |
| Receivables | $167M | $143M | $124M | $100M | $79M | $90M | $69M | · | |
| Prepaid Expense | $75M | $69M | $70M | $102M | $128M | $167M | $97M | $45M | |
| Current Assets | $652M | $416M | $418M | $480M | $557M | $611M | $681M | $390M | |
| PP&E (Net) | $303M | $256M | $249M | $245M | $290M | $302M | $279M | $282M | |
| PP&E (Gross) | $686M | $598M | $575M | $583M | $666M | $663M | $618M | $605M | |
| Accum. Depreciation | $383M | $342M | $326M | $339M | $376M | $362M | $339M | $323M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $960M | $310M | $687M | |
| Intangibles | $754M | $765M | $777M | $812M | $874M | $924M | $138M | $293M | |
| Other Non-current Assets | $138M | $129M | $103M | $81M | $119M | $118M | $88M | $83M | |
| Total Assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Accounts Payable | $125M | $105M | $103M | $82M | $57M | $65M | $39M | $31M | |
| Accrued Liabilities | $94M | $77M | $97M | $106M | $98M | $135M | $97M | $90M | |
| Current Liabilities | $597M | $508M | $488M | $431M | $424M | $497M | $341M | $304M | |
| Capital Leases | $208M | $186M | $168M | $163M | $177M | $156M | $194M | $180M | |
| Deferred Tax | $62M | $32M | $30M | $26M | $26M | $27M | $25M | $25M | |
| Other Non-current Liabilities | $42M | $40M | $39M | $37M | $74M | $58M | $81M | $89M | |
| Total Liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B | $2.37B | $959M | $1.09B | |
| Long-term Debt | $663M | $553M | $649M | $695M | $839M | $1.61B | $287M | $415M | |
| Total Debt | $663M | $553M | $649M | $695M | $839M | · | · | · | |
| Common Stock | $848.0K | $839.0K | $832.0K | $822.0K | $818.0K | $817.0K | $810.0K | $806.0K | |
| Retained Earnings | $3.03B | $2.78B | $2.54B | $2.40B | $2.31B | $1.96B | $1.97B | $2.03B | |
| Treasury Stock | $2.29B | $2.01B | $1.78B | $1.51B | $1.34B | $1.22B | $1.16B | $1.08B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-634.0K | $-8M | $-159M | |
| Stockholders' Equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B | $1.28B | $1.31B | $1.29B | |
| Liabilities + Equity | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Shares Outstanding | 34,033,000 | 35,952,000 | 37,681,000 | 82,232,000 | 81,796,000 | 81,705,000 | 81,021,000 | 52,953,000 |
التدفق النقدي 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $42M | $26M | $14M | $23M | · | · | · | |
| Deferred Tax | $68M | $18M | $11M | $-5M | $-14M | · | · | · | |
| Amort. of Intangibles | $11M | $11M | $36M | $61M | $97M | · | · | · | |
| Restructuring | $6M | $3M | $2M | $19M | $26M | · | · | · | |
| Operating Cash Flow | $470M | $338M | $296M | $192M | $11M | · | · | · | |
| CapEx | $78M | $50M | $49M | $26M | $31M | · | · | · | |
| Investing Cash Flow | $-84M | $-42M | $-48M | $24M | $-552M | · | · | · | |
| Debt Issued | $1.01B | $10M | $2M | $0 | $850M | · | · | · | |
| Net Debt Issued | $112M | $-100M | $-50M | $-151M | $-230M | · | · | · | |
| Stock Repurchased | $240M | $213M | $262M | $123M | $120M | · | · | · | |
| Net Stock Activity | $-240M | $-213M | $-262M | $-123M | $-120M | · | · | · | |
| Financing Cash Flow | $-180M | $-316M | $-302M | $-289M | $-424M | · | · | · | |
| Net Change in Cash | $207M | $-20M | $-54M | $-73M | $-966M | · | · | · | |
| Taxes Paid | $14M | $33M | $31M | $12M | $94M | · | · | · | |
| Free Cash Flow | $393M | $288M | $247M | $166M | $-21M | · | · | · | |
| Levered FCF | $358M | $247M | $193M | $109M | $-106M | · | · | · |
الربحية 7
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| Net Margin | 12.9% | 13.3% | 8.6% | 6.4% | 22.9% | · | · | · | |
| Pretax Margin | 17.7% | 16.7% | 10.3% | 7.7% | -3.2% | · | · | · | |
| EBITDA Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| ROA | 8.7% | 8.6% | 4.9% | 3.3% | 9.7% | · | · | · | |
| ROE | 17.8% | 16.5% | 10.2% | 6.3% | 21.3% | · | · | · | |
| ROIC | 14.1% | 13.4% | 9.0% | 7.1% | 2.3% | · | · | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | 1.3 | · | · | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | 1.0 | · | · | · | |
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| Interest Coverage | 8.4 | 6.5 | 3.4 | 2.7 | 0.6 | · | · | · |
الكفاءة 2
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 12.6 | 13.4 | 14.1 | 16.2 | 16.1 | · | · | · |
معدلات النمو 9
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.8% | 9.2% | 5.0% | 53.7% | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 20.8% | 18.8% | · | · | · | · | |
| Revenue CAGR 5Y | 16.8% | 15.6% | · | · | · | · | · | · | |
| EPS YoY | 13.9% | 82.3% | 65.4% | -68.1% | 372.8% | · | · | · | |
| EPS CAGR 3Y | 50.9% | -1.3% | 35.6% | · | · | · | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 6.1% | 73.3% | 46.5% | -70.0% | 344.1% | · | · | · | |
| Net Income CAGR 3Y | 39.2% | -8.6% | 25.0% | · | · | · | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Net Income TTM | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| Market Cap | $4.24B | $4.57B | $2.57B | $1.45B | $1.63B | · | · | · | |
| Enterprise Value | $4.50B | $4.93B | $3.00B | $1.87B | $2.12B | · | · | · | |
| P/E | 17.7 | 20.6 | 20.1 | 16.8 | 5.6 | · | · | · | |
| P/S | 2.2 | 2.6 | 1.6 | 1.0 | 1.2 | · | · | · | |
| P/B | 2.9 | 3.2 | 1.9 | 1.0 | 1.1 | · | · | · | |
| P / Cash Flow | 9.0 | 13.5 | 8.7 | 7.2 | 155.9 | · | · | · | |
| P / FCF | 10.8 | 15.9 | 10.4 | 8.8 | -78.8 | · | · | · | |
| EV / EBITDA | 11.7 | 14.4 | 13.8 | 11.1 | 26.3 | · | · | · | |
| EV / FCF | 11.5 | 17.1 | 12.2 | 11.3 | -102.6 | · | · | · | |
| EV / Revenue | 2.3 | 2.8 | 1.9 | 1.3 | 1.5 | · | · | · | |
| Earnings Yield | 5.7% | 4.9% | 5.0% | 6.0% | 17.9% | · | · | · |
قائمة الدخل 16
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $501M | $487M | $503M | $462M | $457M | $466M | $448M | $417M | $410M | $413M | $393M | $369M | $365M | $369M | $363M | $354M | |
| Cost of Revenue | $217M | $211M | $205M | $201M | $199M | $200M | $187M | $186M | $183M | $175M | $172M | $169M | $164M | $166M | $159M | $160M | |
| SG&A Expense | $188M | $184M | $183M | $176M | $181M | $175M | $157M | $159M | $155M | $157M | $156M | $166M | $153M | $145M | $142M | $146M | |
| Operating Expenses | $406M | $396M | $392M | $377M | $380M | $376M | $344M | $347M | $341M | $351M | $335M | $341M | $325M | $310M | $317M | $331M | |
| Operating Income | $95M | $91M | $111M | $85M | $77M | $91M | $104M | $70M | $69M | $62M | $59M | $28M | $40M | $59M | $46M | $24M | |
| Interest Expense | $10M | $14M | $11M | $11M | $11M | $13M | $14M | $14M | $15M | $17M | $17M | $16M | $15M | $14M | $16M | $18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | |
| Other Non-op | $3M | $232.0K | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $-1M | $761.0K | |
| Pretax Income | $88M | $78M | $102M | $77M | $69M | $79M | $92M | $58M | $56M | $48M | $45M | $15M | $28M | $49M | $29M | $7M | |
| Income Tax | $16M | $20M | $26M | $16M | $14M | $19M | $21M | $12M | $5M | $11M | $8M | $3M | $4M | $389.0K | $4M | $1M | |
| Net Income | $72M | $42M | $76M | $62M | $54M | $61M | $76M | $46M | $49M | $37M | $40M | $11M | $22M | $46M | $25M | $592.0K | |
| EPS (Basic) | $2.12 | $1.21 | $2.14 | $1.71 | $1.50 | $1.64 | $2.03 | $1.22 | $1.26 | $0.95 | $1.00 | $0.26 | $0.51 | $1.02 | $0.54 | $0.01 | |
| EPS (Diluted) | $2.06 | $1.20 | $2.11 | $1.67 | $1.43 | $1.59 | $1.98 | $1.18 | $1.23 | $0.93 | $0.98 | $0.25 | $0.51 | $1.00 | $0.53 | $0.01 | |
| Shares (Basic) | -71,074,000 | 34,283,000 | 35,725,000 | 36,111,000 | -75,211,000 | 37,140,000 | 37,435,000 | 37,721,000 | -80,571,000 | 38,713,000 | 39,872,000 | 41,399,000 | -91,043,000 | 45,125,000 | 45,425,000 | 45,274,000 | |
| Shares (Diluted) | -72,354,000 | 34,782,000 | 36,230,000 | 37,057,000 | -77,409,000 | 38,233,000 | 38,401,000 | 39,109,000 | -82,300,000 | 39,636,000 | 40,787,000 | 42,184,000 | -92,664,000 | 45,801,000 | 46,121,000 | 46,342,000 | |
| EBITDA | · | $91M | $111M | $85M | · | $91M | $104M | $70M | · | $62M | $59M | $28M | · | $59M | $46M | $23M |
الميزانية العمومية 27
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $147M | $56M | $265M | $200M | $219M | $194M | $265M | $219M | $180M | $183M | $262M | · | $315M | $208M | $328M | |
| Receivables | $167M | $173M | $160M | $192M | $143M | $160M | $144M | $169M | $124M | $138M | $131M | $145M | · | $111M | $97M | $109M | |
| Prepaid Expense | $75M | $79M | $81M | $106M | $69M | $66M | $65M | $79M | $70M | $59M | $58M | $61M | · | $103M | $114M | $128M | |
| Current Assets | $652M | $404M | $303M | $567M | $416M | $450M | $407M | $517M | $418M | $388M | $378M | $473M | · | $533M | $423M | $570M | |
| PP&E (Net) | $303M | $277M | $266M | $257M | $256M | $251M | $246M | $245M | $249M | $273M | $260M | $265M | · | $253M | $276M | $282M | |
| PP&E (Gross) | $686M | $649M | $627M | $608M | $598M | $583M | $583M | $574M | $575M | $600M | $605M | $609M | · | $583M | $621M | $646M | |
| Accum. Depreciation | $383M | $372M | $361M | $351M | $342M | $332M | $337M | $329M | $326M | $327M | $345M | $345M | · | $330M | $346M | $364M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | · | $961M | $961M | $961M | |
| Intangibles | $754M | $757M | $760M | $763M | $765M | $768M | $771M | $774M | $777M | $784M | $792M | $802M | · | $825M | $839M | $855M | |
| Other Non-current Assets | $138M | $137M | $135M | $129M | $129M | $120M | $113M | $108M | $103M | $68M | $66M | $68M | · | $68M | $117M | $121M | |
| Total Assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Accounts Payable | $125M | $97M | $103M | $105M | $105M | $99M | $67M | $91M | $103M | $92M | $88M | $77M | · | $73M | $71M | $64M | |
| Accrued Liabilities | $94M | $93M | $72M | $63M | $77M | $86M | $62M | $87M | $97M | $114M | $98M | $89M | · | $87M | $94M | $94M | |
| Current Liabilities | $597M | $580M | $443M | $577M | $508M | $541M | $385M | $551M | $488M | $509M | $399M | $496M | · | $438M | $371M | $491M | |
| Capital Leases | $208M | $202M | $191M | $188M | $186M | $193M | $182M | $162M | $168M | $160M | $169M | $161M | · | $164M | $166M | $165M | |
| Deferred Tax | $62M | $59M | $57M | $53M | $32M | $34M | $32M | $30M | $30M | $29M | $27M | $26M | · | $27M | $27M | $26M | |
| Other Non-current Liabilities | $42M | $37M | $41M | $38M | $40M | $37M | $35M | $35M | $39M | $48M | $41M | $37M | · | $33M | $62M | $63M | |
| Total Liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | $1.36B | $1.28B | $1.43B | $1.37B | $1.39B | $1.33B | $1.42B | · | $1.36B | $1.32B | $1.49B | |
| Long-term Debt | $663M | $499M | $504M | $553M | $553M | $552M | $650M | $649M | $649M | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Total Debt | · | $499M | $504M | $553M | · | $552M | $650M | $649M | · | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Common Stock | $848.0K | $847.0K | $847.0K | $847.0K | $839.0K | $839.0K | $839.0K | $838.0K | $832.0K | $831.0K | $831.0K | $826.0K | · | $822.0K | $822.0K | $821.0K | |
| Retained Earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | $2.72B | $2.66B | $2.59B | $2.54B | $2.49B | $2.45B | $2.41B | · | $2.38B | $2.35B | $2.33B | |
| Treasury Stock | $2.29B | $2.29B | $2.22B | $2.05B | $2.01B | $1.94B | $1.87B | $1.83B | $1.78B | $1.77B | $1.68B | $1.61B | · | $1.43B | $1.39B | $1.34B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | $1.43B | $1.44B | $1.39B | $1.37B | $1.32B | $1.37B | $1.38B | $1.46B | $1.51B | $1.52B | $1.51B | |
| Liabilities + Equity | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Shares Outstanding | 34,033,000 | 34,023,000 | 34,654,000 | 36,324,000 | 35,952,000 | 36,512,000 | 37,289,000 | 37,716,000 | 37,681,000 | 37,765,000 | 39,526,000 | 40,401,000 | 82,232,000 | 44,232,000 | 45,443,000 | 45,396,000 |
التدفق النقدي 14
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $13M | $8M | $10M | $10M | $11M | $9M | $7M | $6M | $6M | $7M | $3M | $3M | $2M | $6M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $9M | $11M | $12M | $14M | $16M | $19M | |
| Restructuring | $1M | $863.0K | $4M | $310.0K | $388.0K | $510.0K | $322.0K | $2M | $653.0K | $473.0K | $68.0K | $676.0K | $1M | $1M | $1M | $15M | |
| Operating Cash Flow | $124M | $186M | $30M | $131M | $60M | $208M | $-19M | $89M | $60M | $143M | $-18M | $95M | $42M | $108M | $-50M | $91M | |
| CapEx | $27M | $20M | $15M | $16M | $19M | $10M | $11M | $10M | $17M | $2M | $5M | $10M | $7M | $9M | $4M | $5M | |
| Investing Cash Flow | $-28M | $-20M | $-20M | $-16M | $-12M | $-10M | $-11M | $-10M | $-16M | $-2M | $-5M | $-10M | $-7M | $44M | $-7M | $-6M | |
| Debt Issued | $163M | $617M | · | · | $0 | $0 | $0 | $10M | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | $-101M | |
| Stock Repurchased | $0 | $68M | $165M | $8M | $67M | $72M | $41M | $33M | $12M | $90M | $70M | $90M | $78M | · | · | $0 | |
| Net Stock Activity | · | · | · | $-8M | · | · | · | $-33M | · | · | · | $-90M | · | · | · | · | |
| Financing Cash Flow | $163M | $-76M | $-218M | $-50M | $-68M | $-172M | $-42M | $-34M | $-11M | $-140M | $-56M | $-95M | $-78M | $-44M | $-63M | $-103M | |
| Net Change in Cash | $259M | $90M | $-208M | $65M | $-20M | $26M | $-71M | $46M | $34M | $1M | $-78M | $-11M | $-42M | $107M | $-120M | $-18M | |
| Free Cash Flow | · | · | · | $115M | · | · | · | $79M | · | · | · | $85M | · | · | · | $86M | |
| Levered FCF | · | · | · | $106M | · | · | · | $67M | · | · | · | $72M | · | · | · | $71M |
الربحية 7
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| Net Margin | · | 8.6% | 15.2% | 13.4% | · | 13.1% | 16.9% | 11.1% | · | 8.9% | 10.1% | 2.9% | · | 12.4% | 6.7% | 0.62% | |
| Pretax Margin | · | 16.0% | 20.2% | 16.6% | · | 17.0% | 20.6% | 14.0% | · | 11.6% | 11.6% | 4.0% | · | 13.3% | 7.7% | 1.9% | |
| EBITDA Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| ROA | · | 1.5% | 2.9% | 2.2% | · | 2.2% | 2.8% | 1.7% | · | 1.3% | 1.4% | 0.37% | · | 1.4% | 0.74% | 0.06% | |
| ROE | · | 3.0% | 5.4% | 4.3% | · | 4.4% | 5.4% | 3.3% | · | 2.6% | 2.8% | 0.74% | · | 3.1% | 1.7% | 0.16% | |
| ROIC | · | 3.6% | 4.4% | 3.4% | · | 3.5% | 3.8% | 2.7% | · | 2.4% | 2.4% | 1.1% | · | 2.7% | 1.8% | 0.87% |
السيولة والملاءة 5
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.7 | 1.0 | · | 0.8 | 1.1 | 0.9 | · | 0.8 | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.2 | |
| Quick Ratio | · | 0.6 | 0.5 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.8 | · | 1.0 | 0.8 | 0.9 | |
| Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | 6.7 | 10.2 | 7.7 | · | 6.9 | 7.5 | 4.8 | · | 3.7 | 3.5 | 1.8 | · | 4.1 | 3.0 | 1.3 |
الكفاءة 2
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 2.9 | 3.3 | 2.6 | · | 3.1 | 3.3 | 2.7 | · | 3.3 | 3.4 | 2.9 | · | 3.6 | 3.9 | 2.6 |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.92B | $1.88B | $1.79B | · | $1.74B | $1.67B | $1.59B | · | $1.54B | $1.49B | $1.46B | · | $1.45B | $1.44B | $1.45B | |
| Net Income TTM | · | $241M | $275M | $245M | · | $220M | $199M | $134M | · | $133M | $121M | $82M | · | $79M | $381M | $374M | |
| Market Cap | · | $3.92B | $3.59B | $5.61B | · | $3.67B | $3.39B | $2.85B | · | $1.94B | $2.33B | $1.73B | · | $1.71B | $1.61B | $1.65B | |
| Enterprise Value | · | $4.27B | $4.03B | $5.90B | · | $4.01B | $3.84B | $3.23B | · | $2.41B | $2.84B | $2.16B | · | $2.09B | $2.10B | $2.07B | |
| P/E | · | 17.5 | 14.1 | 24.1 | · | 17.7 | 17.9 | 22.6 | · | 16.3 | 21.4 | 23.9 | · | 22.5 | 4.6 | 4.8 | |
| P/S | · | 2.0 | 1.9 | 3.1 | · | 2.1 | 2.0 | 1.8 | · | 1.3 | 1.6 | 1.2 | · | 1.2 | 1.1 | 1.1 | |
| P/B | · | 2.9 | 2.6 | 3.8 | · | 2.6 | 2.4 | 2.0 | · | 1.5 | 1.7 | 1.3 | · | 1.1 | 1.1 | 1.1 | |
| P / Cash Flow | · | · | · | 43.0 | · | · | · | 31.9 | · | · | · | 17.4 | · | · | · | 18.1 | |
| P / FCF | · | · | · | 49.0 | · | · | · | 36.1 | · | · | · | 20.5 | · | · | · | 19.3 | |
| EV / EBITDA | · | 46.8 | 36.3 | 69.0 | · | 44.3 | 37.0 | 46.0 | · | 39.0 | 48.5 | 76.8 | · | 35.1 | 45.6 | 89.6 | |
| EV / FCF | · | · | · | 51.5 | · | · | · | 41.0 | · | · | · | 25.6 | · | · | · | 24.1 | |
| EV / Revenue | · | 2.2 | 2.1 | 3.3 | · | 2.3 | 2.3 | 2.0 | · | 1.6 | 1.9 | 1.5 | · | 1.4 | 1.5 | 1.4 | |
| Earnings Yield | · | 5.7% | 7.1% | 4.2% | · | 5.6% | 5.6% | 4.4% | · | 6.2% | 4.7% | 4.2% | · | 4.5% | 21.9% | 20.8% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $1.95B | $1.79B | $1.58B | $1.45B | — |
| هامش الربح التشغيلي % | 19.6% | 19.1% | 13.7% | 11.6% | — |
| صافي الدخل | $252M | $237M | $137M | $93M | — |
| EPS المخفف | $7.04 | $6.18 | $3.39 | $2.05 | — |
الميزانية العمومية
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.5 | 0.4 | 0.5 | 0.5 | — |
| النسبة الحالية | 1.1 | 0.8 | 0.9 | 1.1 | — |
| النسبة السريعة | 1.0 | 0.7 | 0.7 | 0.9 | — |
التدفق النقدي
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $393M | $288M | $247M | $166M | — |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 403 مقدمي إقرار · $3.0B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 62 (+11 مقابل الربع السابق) | 30 (-22 مقابل الربع السابق) | 137 (+2 مقابل الربع السابق) | 121 (-9 مقابل الربع السابق) | +241K |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD GROUP INC | $418746711 | 4047035 | 14,07% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $297558184 | 2386958 | 10,00% | الأسهم |
| FMR LLC | $280021015 | 2246278 | 9,41% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $208992241 | 1676499 | 7,02% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $183742358 | 1473948 | 6,17% | الأسهم |
| STATE STREET CORP | $173212203 | 1389477 | 5,82% | الأسهم |
| Capital World Investors | $132593736 | 1063643 | 4,46% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $95719361 | 767678 | 3,22% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $87910731 | 705204 | 2,95% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $78581301 | 630365 | 2,64% | الأسهم |
| Alyeska Investment Group, L.P. | $68807458 | 551961 | 2,31% | الأسهم |
| Fisher Asset Management, LLC | $63050035 | 505776 | 2,12% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60245186 | 483276 | 2,02% | الأسهم |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $44010839 | 353047 | 1,48% | الأسهم |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $37728848 | 302654 | 1,27% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $32342164 | 259443 | 1,09% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $30437360 | 244163 | 1,02% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $26065659 | 209094 | 0,88% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $23386341 | 187601 | 0,79% | الأسهم |
| SG Capital Management LLC | $22238845 | 178396 | 0,75% | الأسهم |
| TWO SIGMA ADVISERS, LP | $19876587 | 192100 | 0,67% | الأسهم |
| ALGERT GLOBAL LLC | $19323048 | 155006 | 0,65% | الأسهم |
| MORGAN STANLEY | $18731418 | 150260 | 0,63% | الأسهم |
| Public Sector Pension Investment Board | $17393810 | 139530 | 0,58% | الأسهم |
| Corient Private Wealth LP | $16950396 | 135973 | 0,57% | الأسهم |
| WESTPORT ASSET MANAGEMENT INC | $15677117 | 125759 | 0,53% | الأسهم |
| Bank of New York Mellon Corp | $15262248 | 122431 | 0,51% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $14091816 | 113042 | 0,47% | الأسهم |
| MACKENZIE FINANCIAL CORP | $13510152 | 108376 | 0,45% | الأسهم |
| Qube Research & Technologies Ltd | $12647380 | 101455 | 0,43% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $12502650 | 100294 | 0,42% | الأسهم |
| RHUMBLINE ADVISERS | $10647181 | 85410 | 0,36% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $9671247 | 77581 | 0,33% | الأسهم |
| Foresight Group Ltd Liability Partnership | $9636366 | 77264 | 0,32% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $9436388 | 75697 | 0,32% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $8879782 | 77048 | 0,30% | الأسهم |
| BlackRock, Inc. | $8832036 | 70849 | 0,30% | الأسهم |
| LAZARD ASSET MANAGEMENT LLC | $8696157 | 69759 | 0,29% | الأسهم |
| Swiss National Bank | $8638938 | 69300 | 0,29% | الأسهم |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $8557000 | 68639 | 0,29% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $8419536 | 67540 | 0,28% | الأسهم |
| Hillsdale Investment Management Inc. | $8077968 | 64800 | 0,27% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $8030847 | 64422 | 0,27% | الأسهم |
| RENAISSANCE GROUP LLC | $7608748 | 61036 | 0,26% | الأسهم |
| AMERIPRISE FINANCIAL INC | $7563622 | 60674 | 0,25% | الأسهم |
| GOLDMAN SACHS GROUP INC | $7528716 | 60394 | 0,25% | الأسهم |
| Allianz Asset Management GmbH | $7053013 | 56578 | 0,24% | الأسهم |
| LONESTAR CAPITAL MANAGEMENT LLC | $6856300 | 55000 | 0,23% | الأسهم |
| Legal & General Group Plc | $6503387 | 52169 | 0,22% | الأسهم |
| Phocas Financial Corp. | $6345443 | 50902 | 0,21% | الأسهم |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $6335869 | 54975 | 0,21% | الأسهم |
| FIRST TRUST ADVISORS LP | $6152968 | 49358 | 0,21% | الأسهم |
| ExodusPoint Capital Management, LP | $5906141 | 47378 | 0,20% | الأسهم |
| KESTREL INVESTMENT MANAGEMENT CORP | $5896418 | 47300 | 0,20% | الأسهم |
| LEUTHOLD GROUP, LLC | $5622914 | 45106 | 0,19% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $5482297 | 43978 | 0,18% | الأسهم |
| Connor, Clark & Lunn Investment Management Ltd. | $5313757 | 42626 | 0,18% | الأسهم |
| LGT Fund Management Co Ltd. | $4992633 | 40050 | 0,17% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4840500 | 42000 | 0,16% | الأسهم |
| Trexquant Investment LP | $4814120 | 38618 | 0,16% | الأسهم |
| FARLEY CAPITAL L.P. | $4644333 | 37256 | 0,16% | الأسهم |
| SEI INVESTMENTS CO | $4541490 | 36431 | 0,15% | الأسهم |
| CHURCHILL MANAGEMENT Corp | $4474806 | 35171 | 0,15% | الأسهم |
| INTECH INVESTMENT MANAGEMENT LLC | $4270726 | 34259 | 0,14% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $3909088 | 31358 | 0,13% | الأسهم |
| HSBC HOLDINGS PLC | $3726330 | 29614 | 0,13% | الأسهم |
| PANAGORA ASSET MANAGEMENT INC | $3568268 | 28624 | 0,12% | الأسهم |
| Smith Group Asset Management, LLC | $3304113 | 26505 | 0,11% | الأسهم |
| OP Asset Management Ltd | $3295387 | 26435 | 0,11% | الأسهم |
| Horizon Investments, LLC | $3257730 | 21000 | 0,11% | الأسهم |
| Atom Investors LP | $3165242 | 25391 | 0,11% | الأسهم |
| FORMULA GROWTH LTD | $3140933 | 25196 | 0,11% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $3064891 | 24586 | 0,10% | الأسهم |
| BARCLAYS PLC | $2926019 | 23472 | 0,10% | الأسهم |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $2840627 | 22787 | 0,10% | الأسهم |
| NewEdge Wealth, LLC | $2790514 | 22385 | 0,09% | الأسهم |
| Elo Mutual Pension Insurance Co | $2724943 | 21859 | 0,09% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $2717588 | 21800 | 0,09% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $2695523 | 21623 | 0,09% | الأسهم |
| MetLife Investment Management, LLC | $2499807 | 20053 | 0,08% | الأسهم |
| Global Alpha Capital Management Ltd. | $2430995 | 19501 | 0,08% | الأسهم |
| FIFTH THIRD BANCORP | $2403502 | 19280 | 0,08% | الأسهم |
| ROYCE & ASSOCIATES LP | $2376768 | 19066 | 0,08% | الأسهم |
| Boston Partners | $2293116 | 18393 | 0,08% | الأسهم |
| Quantinno Capital Management LP | $2288134 | 18355 | 0,08% | الأسهم |
| Grantham, Mayo, Van Otterloo & Co. LLC | $2256097 | 18098 | 0,08% | الأسهم |
| LGT CAPITAL PARTNERS LTD. | $2206482 | 17700 | 0,07% | الأسهم |
| IEQ CAPITAL, LLC | $2199751 | 17646 | 0,07% | الأسهم |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2141829 | 20700 | 0,07% | الأسهم |
| Bridgewater Associates, LP | $2138044 | 17151 | 0,07% | الأسهم |
| CITIGROUP INC | $2106879 | 16901 | 0,07% | الأسهم |
| CITADEL ADVISORS LLC | $2106754 | 16900 | 0,07% | عقد خيار الشراء |
| Banque Cantonale Vaudoise | $2082000 | 16700 | 0,07% | الأسهم |
| Mariner, LLC | $2075942 | 16653 | 0,07% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2064120 | 16558 | 0,07% | الأسهم |
| Illinois Municipal Retirement Fund | $2054147 | 16478 | 0,07% | الأسهم |
| Gotham Asset Management, LLC | $2014256 | 16158 | 0,07% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1982094 | 15900 | 0,07% | عقد خيار الشراء |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1977731 | 15865 | 0,07% | الأسهم |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1902312 | 15260 | 0,06% | الأسهم |
المطلعون على الشركة 111 من المطلعين · مسؤولون 46 · مديرون 24
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Daniel Hamburger | President and CEO | 31 أغسطس، 2015 S | 142136 | 0 | 0 | $0 |
| Michael O Randolfi | SVP, Chief Financial Officer | 28 أغسطس، 2020 F | 84391 | 0 | 0 | $0 |
| Timothy J Wiggins | SVP & Chief Financial Officer | 25 فبراير، 2016 S | 44939 | 0 | 0 | $0 |
| Richard Gunst | Chief Financial Officer | 1 فبراير، 2012 M | 9356 | 0 | 0 | $0 |
| Amelia Manning | President, Chamberlain Univ. | 15 يوليو، 2026 A | 4317 | 0 | 0 | $0 |
| Karen Sue Cox | President, Chamberlain Univ. | 8 مايو، 2026 S | 31596 | 0 | 1 | $-249000 |
| Scott Liles | President, Medical and Vet | 15 إبريل، 2026 F | 13103 | 0 | 0 | $0 |
| Evan Trent | President, Adtalem Elevate | 13 نوفمبر، 2025 F | 24134 | 0 | 0 | $0 |
| Thiago Aguiar Sayao | Group President, Business &Law | 28 فبراير، 2020 S | 1830 | 0 | 0 | $0 |
| Carlos Filgueiras | Group President, Tech/Business | 13 فبراير، 2019 S | 11775 | 0 | 0 | $0 |
| Donna M Loraine | President, Carrington Colleges | 6 نوفمبر، 2018 M | 6701 | 0 | 0 | $0 |
| Susan Groenwald | President, Chamberlain | 9 فبراير، 2018 M | 34402 | 0 | 0 | $0 |
| John P Roselli | President, Becker Professional | 1 سبتمبر، 2017 S | 13730 | 0 | 0 | $0 |
| Eric P. Dirst | President, ATGE Shared Ops | 31 أغسطس، 2017 S | 14800 | 0 | 0 | $0 |
| Robert A Paul | President, DeVry University | 25 أغسطس، 2017 M | 28426 | 0 | 0 | $0 |
| Steven Riehs | President, Med, Prof & Online | 2 سبتمبر، 2016 M | 28062 | 0 | 0 | $0 |
| Jeffrey Richard Akens | President, Carrington College | 29 أغسطس، 2015 F | 6752 | 0 | 0 | $0 |
| Christopher Caywood | President, Online Services | 1 مارس، 2013 F | 7378 | 0 | 0 | $0 |
| Andrew A Jeon | President, DeVry Medical Int'l | 2 نوفمبر، 2012 F | 5655 | 0 | 0 | $0 |
| William B. Hughson | President, Medical & | 29 أغسطس، 2012 A | 2143 | 0 | 0 | $0 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 18 مايو، 2026 F | 5271 | 0 | 1 | $-128072 |
| Michael Betz | Pres. Walden University & CDO | 13 نوفمبر، 2025 F | 33286 | 0 | 0 | $0 |
| Maurice Herrera | SVP - Chief Marketing Officer | 13 نوفمبر، 2025 F | 20584 | 0 | 0 | $0 |
| Megan Noel | Chief Corp. Affairs Officer | 12 نوفمبر، 2025 A | 2226 | 0 | 0 | $0 |
| Sara Hill | CHRO | 12 نوفمبر، 2025 A | 10276 | 0 | 0 | $0 |
| Blake Simpson | SVP, Chief Comms & CA Officer | 5 ديسمبر، 2024 F | 8795 | 0 | 0 | $0 |
| Steven Tom | SVP Chief Customer Officer | 13 نوفمبر، 2024 A | 13255 | 0 | 0 | $0 |
| Cheryl James | SVP, CHRO | 28 فبراير، 2024 F | 17485 | 0 | 0 | $0 |
| John W Danaher MD | Pres. - Adtalem Med & Vet | 25 أغسطس، 2023 F | 38718 | 0 | 0 | $0 |
| James Raymond Bartholomew | SVP - Chamberlain University | 26 أغسطس، 2022 F | 6418 | 0 | 0 | $0 |
| Holland Katherine Alice Boden | Group Pres, Adtalem Health | 30 أغسطس، 2021 F | 32148 | 0 | 0 | $0 |
| Fernando Lau | SVP, Chief Marketing Officer | 28 أغسطس، 2021 F | 19253 | 0 | 0 | $0 |
| Christopher C Nash | SVP, Chief Information Officer | 28 أغسطس، 2021 F | 25741 | 0 | 0 | $0 |
| Donna Jennings | SVP, Human Resources | 28 أغسطس، 2021 F | 30898 | 0 | 0 | $0 |
| Chaka M Patterson | SVP and General Counsel | 28 أغسطس، 2020 F | 5202 | 0 | 0 | $0 |
| Mehul R Patel | Group Pres, Financial Services | 7 نوفمبر، 2019 F | 11258 | 0 | 0 | $0 |
| Kathleen Carroll | Vice President, Controller | 28 أغسطس، 2019 A | 5497 | 0 | 0 | $0 |
| Lisa M Sodeika | SVP, Corporate Affairs | 28 أغسطس، 2019 A | 24151 | 0 | 0 | $0 |
| Patrick J Unzicker | Principal Financial Officer | 27 أغسطس، 2019 F | 36360 | 0 | 0 | $0 |
| Catherine C. Anderson | SVP, Strategy & Innovation | 26 أغسطس، 2019 F | 6025 | 0 | 0 | $0 |
| Gena L Ashe | SVP, CLO and Secretary | 23 أغسطس، 2017 A | 4420 | 0 | 0 | $0 |
| Gregory S Davis | SVP and General Counsel | 1 سبتمبر، 2016 S | 22433 | 0 | 0 | $0 |
| Adriano Allegrini | VP, Strategy and Bus. Develop. | 29 أغسطس، 2015 F | 7004 | 0 | 0 | $0 |
| Sharon Thomas Parrott | SVP, Gov. & Regulatory Affairs | 5 نوفمبر، 2014 A | 5610 | 0 | 0 | $0 |
| David J Pauldine | Executive Vice President & | 25 إبريل، 2014 M | 30242 | 0 | 0 | $0 |
| Thomas C Shepherd | Executive Vice President and | 27 مايو، 2011 M | 0 | 0 | 0 | $0 |
| Michael W Malafronte | مدير | 11 مارس، 2026 P | 25395 | 5 | 0 | $3844716 |
| William V Krehbiel | مدير | 13 نوفمبر، 2025 F | 16303 | 0 | 0 | $0 |
| Betty M. Vandenbosch | مدير | 13 نوفمبر، 2025 F | 2584 | 0 | 0 | $0 |
| Kenneth J Phelan | مدير | 13 نوفمبر، 2025 F | 19836 | 1 | 0 | $49931 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 1 حيازة
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| International Value Advisers, LLC, Charles de Vaulx ×18 إيداعات | 7 أغسطس، 2020 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 80 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| MYLD · Cambria ETF Trust | 0,94% | 2418 NS | 30 إبريل، 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,80% | 190016 NS | 31 مايو، 2026 | N-PORT |
| VUSE · ETF Series Solutions | 0,53% | 31159 NS | 31 مايو، 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 0,47% | 919 NS | 30 إبريل، 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,46% | 136827 NS | 30 إبريل، 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,33% | 29825 NS | 30 إبريل، 2026 | N-PORT |
| PSC · Principal Exchange-Traded Funds | 0,24% | 44826 NS | 30 يونيو، 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 10711 NS | 30 إبريل، 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 13071 NS | 30 إبريل، 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,20% | 2228 NS | 30 إبريل، 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,20% | 46807 NS | 31 مايو، 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1290 NS | 30 إبريل، 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,18% | 217961 NS | 30 إبريل، 2026 | N-PORT |
| SAA · ProShares Trust | 0,18% | 412 NS | 31 مايو، 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,14% | 29761 NS | 30 إبريل، 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,14% | 1078 NS | 31 مايو، 2026 | N-PORT |
| FNDA · SCHWAB STRATEGIC TRUST | 0,13% | 98138 NS | 31 مايو، 2026 | N-PORT |
| RSSL · Global X Funds | 0,12% | 14797 NS | 30 إبريل، 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,11% | 12017 NS | 30 إبريل، 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,11% | 9365 NS | 31 مايو، 2026 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0,10% | 15550 NS | 30 إبريل، 2026 | N-PORT |
| ITWO · ProShares Trust | 0,10% | 1606 NS | 31 مايو، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,09% | 111249 NS | 30 إبريل، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,09% | 165865 NS | 31 مايو، 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 2779 NS | 30 إبريل، 2026 | N-PORT |
| UWM · ProShares Trust | 0,06% | 1255 NS | 31 مايو، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,04% | 28991 NS | 30 إبريل، 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,04% | 1493 NS | 30 إبريل، 2026 | N-PORT |
| URTY · ProShares Trust | 0,04% | 1270 NS | 31 مايو، 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,03% | 718 NS | 31 مايو، 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,02% | 30161 NS | 30 إبريل، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 91108 NS | 30 إبريل، 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,02% | 913 NS | 31 مايو، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 1387 NS | 31 مايو، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 3765 NS | 30 إبريل، 2026 | N-PORT |
| SFGV · EA Series Trust | 0,02% | 1945 NS | 29 مايو، 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 32 NS | 31 مايو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 3622 NS | 30 إبريل، 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,01% | 15512 NS | 31 مايو، 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2002 NS | 30 إبريل، 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 1000 NS | 31 مايو، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 8199 NS | 30 إبريل، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 10368 NS | 30 إبريل، 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,01% | 20540 NS | 31 مايو، 2026 | N-PORT |
| EBI · RBB Fund Trust | 0,00% | 200 NS | 31 مايو، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VBR · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 يوليو، 2026 | يومي |
| VFQY · VANGUARD WELLINGTON FUND | — | — | 30 يوليو، 2026 | يومي |